Davis Andrew 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Mar 10, 2023
Insider Transaction Report
Form 4
Davis Andrew
SVP, Chief Business Officer
Transactions
- Award
Class A Common Stock
2023-03-08+74,236→ 225,632 total - Award
Performance-based Restricted Stock Units
2023-03-08+37,118→ 37,118 totalExp: 2026-02-28→ Class A Common Stock (37,118 underlying)
Footnotes (2)
- [F1]The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
- [F2]Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.